Arbutus Biopharma Corp
Nasdaq · Healthcare · Pharmaceutical Preparations · Warminster, PA
ABUS chart
What traders are saying about $ABUS
Latest postsArbutus Biopharma Corp news
- Arbutus Biopharma Corporation expected to post a loss of 2 cents a share - Earnings Preview
TradingView ·
- Moderna Faces Key US Court Appeal Over COVID Vaccine Patent Dispute
www.nationpathindia.com ·
- Arbutus Biopharma Stock Price Forecast. Should You Buy ABUS?
StockInvest.us ·
- Taxpayers Funded the mRNA Revolution. Now Big Pharma Battles Over Billions—Could the Public Pay Again?
Trial Site News ·
- MRNA Q3 Earnings Beat on COVID Sales, Raises '26 Outlook, Stock Rises
Yahoo Finance ·
- In Moderna Row, Fed. Circ. Mulls What's 'For The Government'
Law360 ·
- Arbutus Biopharma Corporation
Reuters ·
- Moderna pressed by US judges on billion-dollar COVID patent defense
Reuters ·
- Who Pays for the 500 Million COVID Doses? Section 1498 in Arbutus v. Moderna
Patently-O ·
- ABUS Q3'26 Earnings: revenue estimate is 1.00M USD
TradingView ·
- Arbutus Announces FDA Clinical Hold is Lifted on IND Application for AB-101, an Oral PD-L1 Inhibitor
Yahoo Finance ·
- Arbutus Announces Final Results of Its US$230 Million Modified “Dutch Auction” Tender Offer
Yahoo Finance ·
Arbutus Biopharma Corp key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $14.1M | $6.2M | $18.1M | $39.0M |
| Net income | -$33.5M | -$69.9M | -$72.8M | -$69.5M |
| Diluted EPS | $-0.17 | $-0.38 | $-0.44 | $-0.46 |
| Total assets (year end) | $94.6M | $131.7M | $144.4M | $195.4M |
| Cash and equivalents (year end) | $18.0M | $36.3M | $26.3M | $30.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Arbutus Biopharma Corp
- Ticker
- ABUS (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Warminster, PA
- Incorporated in
- British Columbia, Canada
- Fiscal year end
- December 31
- SEC CIK
- 1447028
- Former names
- TEKMIRA PHARMACEUTICALS CORP, TEKMIRA PHARMACEUTICALS Corp
Frequently asked questions
What exchange is Arbutus Biopharma Corp listed on?
Arbutus Biopharma Corp trades on the Nasdaq under the ticker symbol ABUS.
What industry is Arbutus Biopharma Corp in?
Arbutus Biopharma Corp is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Arbutus Biopharma Corp headquartered?
Arbutus Biopharma Corp's business address on file with the SEC is in Warminster, PA.
When does Arbutus Biopharma Corp's fiscal year end?
Arbutus Biopharma Corp's fiscal year ends on December 31.
How much revenue did Arbutus Biopharma Corp report?
Arbutus Biopharma Corp reported $14.1M in revenue for calendar year 2025, according to its SEC filings.